Biofilm mediated integrin activation and directing acceleration of colorectal cancer

IF 2.2 4区 医学 Q4 IMMUNOLOGY
Apmis Pub Date : 2024-09-09 DOI:10.1111/apm.13466
Vaijayanthi Saravanan, Vinoj Gopalakrishnan, Maria Infant Majula Shifani Mahendran, Rajan Vaithianathan, Sowmya Srinivasan, Vinoth Boopathy, SriKrishna Krishnamurthy
{"title":"Biofilm mediated integrin activation and directing acceleration of colorectal cancer","authors":"Vaijayanthi Saravanan,&nbsp;Vinoj Gopalakrishnan,&nbsp;Maria Infant Majula Shifani Mahendran,&nbsp;Rajan Vaithianathan,&nbsp;Sowmya Srinivasan,&nbsp;Vinoth Boopathy,&nbsp;SriKrishna Krishnamurthy","doi":"10.1111/apm.13466","DOIUrl":null,"url":null,"abstract":"<p>Bacterial biofilm plays a vital role in influencing several diseases, infections, metabolic pathways and communication channels. Biofilm influence over colorectal cancer (CRC) has been a booming area of research interest. The virulence factors of bacterial pathogen have a high tendency to induce metabolic pathway to accelerate CRC. The bacterial species biofilm may induce cancer through regulating the major signalling pathways responsible for cell proliferation, differentiation, survival and growth. Activation of cancer signals may get initiated from the chronic infections through bacterial biofilm species. Integrin mediates in the activation of major pathway promoting cancer. Integrin-mediated signals are expected to be greatly influenced by biofilm. Integrins are identified as an important dimer, whose dysfunction may alter the signalling cascade specially focusing on TGF-β, PI3K/Akt/mToR, MAPK and Wnt pathway. Along with biofilm shield, the tumour gains greater resistance from radiation, chemotherapy and also from other antibiotics. The biofilm barrier is known to cause challenges for CRC patients undergoing treatment.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"132 10","pages":"688-705"},"PeriodicalIF":2.2000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apmis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apm.13466","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Bacterial biofilm plays a vital role in influencing several diseases, infections, metabolic pathways and communication channels. Biofilm influence over colorectal cancer (CRC) has been a booming area of research interest. The virulence factors of bacterial pathogen have a high tendency to induce metabolic pathway to accelerate CRC. The bacterial species biofilm may induce cancer through regulating the major signalling pathways responsible for cell proliferation, differentiation, survival and growth. Activation of cancer signals may get initiated from the chronic infections through bacterial biofilm species. Integrin mediates in the activation of major pathway promoting cancer. Integrin-mediated signals are expected to be greatly influenced by biofilm. Integrins are identified as an important dimer, whose dysfunction may alter the signalling cascade specially focusing on TGF-β, PI3K/Akt/mToR, MAPK and Wnt pathway. Along with biofilm shield, the tumour gains greater resistance from radiation, chemotherapy and also from other antibiotics. The biofilm barrier is known to cause challenges for CRC patients undergoing treatment.

生物膜介导的整合素激活与结直肠癌的加速发展。
细菌生物膜在影响多种疾病、感染、代谢途径和通信渠道方面发挥着至关重要的作用。生物膜对结直肠癌(CRC)的影响一直是研究兴趣的热点领域。细菌病原体的毒力因子极易诱导新陈代谢途径,从而加速 CRC 的发生。细菌生物膜可通过调节细胞增殖、分化、存活和生长的主要信号通路诱发癌症。癌症信号的激活可能源于细菌生物膜的慢性感染。整合素介导了主要致癌途径的激活。整合素介导的信号预计会受到生物膜的极大影响。整合素是一种重要的二聚体,其功能障碍可能会改变信号级联,特别是 TGF-β、PI3K/Akt/mToR、MAPK 和 Wnt 通路。有了生物膜屏障,肿瘤对放射线、化疗和其他抗生素的抵抗力就会增强。众所周知,生物膜屏障会给正在接受治疗的癌症患者带来挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Apmis
Apmis 医学-病理学
CiteScore
5.20
自引率
0.00%
发文量
91
审稿时长
2 months
期刊介绍: APMIS, formerly Acta Pathologica, Microbiologica et Immunologica Scandinavica, has been published since 1924 by the Scandinavian Societies for Medical Microbiology and Pathology as a non-profit-making scientific journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信